Dual trigger versus human chorionic gonadotropin trigger for blastocyst quality and cumulative live birth
Authors:
- 16 November 2024
- journal article
- research article
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 41 (12) , 3445-3453
Abstract
Purpose To evaluate the difference in the number of euploid blastocysts and cumulative live birth rate (LBR) between dual and human chorionic gonadotropin (hCG) triggers in poor and normal ovarian responders undergoing preimplantation genetic testing (PGT) cycles. Methods This retrospective cohort study was enrolled from July 2018 to December 2021 and followed up until June 2024 at a single reproductive medical center. Overall, 1040 in vitro fertilization (IVF)-PGT and 784 frozen-thawed embryo transfer (FET) cycles were assessed. Dual (triptorelin acetate 0.2 mg and recombinant hCG [rhCG] 250 µg) or hCG (rhCG 250 µg) trigger was used for oocyte maturation in the gonadotropin-releasing hormone antagonist protocol and PGT cycles. We assessed the embryo outcomes and FET cumulative pregnancy outcomes. Results The number of oocytes retrieved (10.17 ± 5.22 vs 10.27 ± 5.14, P = 0.789), MII oocytes (8.24 ± 4.26 vs 8.28 ± 4.05, P = 0.888), blastocysts (2.16 ± 1.50 vs 2.12 ± 1.49, P = 0.729), euploid blastocysts (1.06 ± 1.14 vs 1.09 ± 1.23, P = 0.726), and the rate of cumulative LBR (24.9% vs 24.9%, P = 1.000) in the dual trigger group were comparable with those in the hCG group. The trigger method was not correlated with higher LBR based on logistic regression analysis (odds ratio[OR] = 1.040 [0.778–1.392], P = 0.790). Conclusion For poor and normal ovarian responders, the dual trigger, compared with the hCG trigger, did not improve the PGT embryo outcomes and FET cumulative pregnancy outcomes.Keywords
Funding Information
- National Natural Science Foundation of China (82171626)
- National Key Research and Development Program of Chin (2023YFC2705504)
- Tibetan Plateau Scientific Expedition and Research Program (2019QZKK0606)
This publication has 33 references indexed in Scilit:
- Standard human chorionic gonadotropin versus double trigger for final oocyte maturation results in different granulosa cells gene expressions: a pilot studyFertility and Sterility, 2016
- Validation of a next-generation sequencing–based protocol for 24-chromosome aneuploidy screening of blastocystsFertility and Sterility, 2016
- Triggering final follicular maturation- hCG, GnRH-agonist or both, when and to whom?Journal of Ovarian Research, 2015
- Co-administration of GnRH-agonist and hCG, for final oocyte maturation (double trigger), in patients with low proportion of mature oocytesGynecological Endocrinology, 2014
- Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity ratesFertility and Sterility, 2014
- Combined administration of gonadotropin-releasing hormone agonist with human chorionic gonadotropin for final oocyte maturation in GnRH antagonist cycles for in vitro fertilization.2014
- AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysisHuman Reproduction Update, 2010
- Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized studyFertility and Sterility, 2008
- Noninvasive assessment of human embryo nutrient consumption as a measure of developmental potentialFertility and Sterility, 2001
- Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transferFertility and Sterility, 2000